NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences climbed around 16 percent in early trade on the Nasdaq after the firm announced that it had sold one of its Helicos Genetic Analysis Systems to the Turku Centre for Biotechnology in Turku, Finland.
The firm's shares were up $.18 at $1.30 less than an hour after the market opened.
The Turku Centre for Biotechnology's purchase represents the 10th sale of Helicos' HeliScope Single Molecule Sequencer. According to Helicos, there are 12 Helicos systems currently installed and operating at customer sites around the world.
Ron Lowy, Helicos' CEO, said in a statement that the firm averaged one placement per month during 2009 for the Helicos system.